Zolis, I would agree with you if this was not a time where we were in a 'vaccine' race with other companies backed by the most powerful governments of the world. Because of this, that box really needs to be opened fast to see if the cat is dead or alive or barely breathing.

Generex / NGIO has put out so many timelines and needs to let us know if they have something actually happening or not because right now with what we are seeing are vaccines that are being promoted by governments worldwide and soon their boosters and now pushed extremely heavily while we can't even get out of the box and we are having to guess if a cat is dead or alive.

We have waited for months and the question everyday is just how much longer is this wait going to be, until then the guessing won't stop until the management puts out the cat is alive or dead.

Generex / NGIO needs to succeed. They need to not only get the IND put in, but they need the IPO to be in. They need to get Excellegan sold overseas and to the hospital(s). Those three goals are all doable and all should be met by October. These should be updates we should be hearing about.